Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A0VB
|
|||
| Former ID |
DNC002227
|
|||
| Drug Name |
ISIS 111118
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cytohesin-2 messenger RNA (CYTH2 mRNA) | Target Info | . | [1] |
| KEGG Pathway | Endocytosis | |||
| Pathway Interaction Database | Arf6 signaling events | |||
| Class I PI3K signaling events | ||||
| Arf1 pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,271,029, Antisense inhibition of cytohesin-2 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.